Thomas Martens, MD and Gregg Simonson, PhD., discuss selecting the right patients for CGM, how CGM data can improve diabetes management, and best practices for implementing CGM in your office.
This activity has been funded by an unrestricted educational grant from Abbott Diabetes Care.
Thomas Martens, MD
Research Contracts/Grants: Abbott Diabetes Care, Dexcom Inc, Eli Lily, Medtronic, Novo Nordisk, Senseonics
Tabassum Salam, MD, FACP
Gregg Simonson, PhD
Consultantship: Abbott Diabetes Care, Merck
Relevant commercial relationships appear in italics below each individual’s name. All others have nothing to disclose. All potential conflicts of interest have been mitigated.